DEINOVE Logo

DEINOVE | ALDEI - Profile, Filings, Stock Info & Investor Relations Data

DEINOVE | ALDEI
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
France
Founded
2006
DEINOVE (ALDEI)

About DEINOVE

DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the “microbial dark matter”. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance.

The new therapies discovered and developed by DEINOVE target superbugs (microbes that have become resistant to one or more antimicrobials) that cause life-threatening infections which are now spreading at high speed.

Employees

50

Market Presence

Worldwide

Headquarters

1682 RUE DE LA VALSIERE
34790, GRABELS
France

DEINOVE (ALDEI)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

DEINOVE (ALDEI)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

DEINOVE (ALDEI)
Stock & Investor Information

ISINs

FR0010879056
FR0011041698

LEI

969500BEJSRFER0F2K08

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View DEINOVE on main exchange

Industry Classification